Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Top Performance

Predictions

sell
Novavax Inc.

Start price
Target price
Perf. (%)
€34.98
27.08.22
€16.00
27.08.23
-38.94%
13.10.22

Very low/no dividend yield expected
very negative Cash Flow expected
ROE lower than 10% per year
high free float
geldnutzer 
27.08.22 50%
buy
Albireo Pharma Inc.

Start price
Target price
Perf. (%)
€26.40
12.10.21
€29.00
12.10.22
-15.27%
13.10.22

Could be worthwhile Investment >10% per year
melinda 
12.10.21 50%
buy
Avenue Therapeutics Inc.

Start price
Target price
Perf. (%)
€17.10
10.10.21
€15.00
10.10.22
-84.33%
11.10.22

Could be worthwhile Investment >10% per year
Some uniques
yester 
10.10.21 0%
buy
scPharmaceuticals

Start price
Target price
Perf. (%)
€6.15
29.09.22
€8.00
31.12.24
-23.25%
10.10.22

Could be very worthwhile Investment >20% year
BiotechBee 
29.09.22 50%
sell
Avenue Therapeutics Inc.

Start price
Target price
Perf. (%)
€14.42
03.10.22
-
03.10.23
-81.66%
07.10.22

Risky Investment
quelbe60 
03.10.22 50%
buy
Motus GI Holdings Inc.

Start price
Target price
Perf. (%)
€2.26
03.10.22
€3.00
03.10.23
22.12%
06.10.22

Could be worthwhile Investment >10% per year
Capable Management
Very good company culture
Little innovation
me8 
03.10.22 0%
sell
Avenue Therapeutics Inc.

Start price
Target price
Perf. (%)
€14.38
03.10.22
€7.00
03.10.23
-44.51%
06.10.22

Good culture
Probably not worthwhile Investment
Below average Management
No Innovation
me8 
03.10.22 0%
sell
Avenue Therapeutics Inc.

Start price
Target price
Perf. (%)
€10.76
30.09.22
-
30.09.23
39.41%
03.10.22

Risky Investment
quelbe60 
30.09.22 50%
sell
Inovio Pharma

Start price
Target price
Perf. (%)
€1.88
20.09.22
€1.60
20.09.23
-7.46%
03.10.22

Very low/no dividend yield expected
Risky balance sheet
ROE lower than 10% per year
Increased challenges to pay loans and raise capital
geldnutzer 
20.09.22 50%
sell
Omeros Corp.

Start price
Target price
Perf. (%)
€7.20
02.10.21
-
02.10.22
-53.29%
03.10.22

Probably not worthwhile Investment
Lokrim 
02.10.21 20%
buy
Adaptimmune Therapeutics PLC ADR

Start price
Target price
Perf. (%)
€1.16
27.09.22
-
27.09.23
-4.31%
01.10.22

Risky Investment
quelbe60 
27.09.22 50%
buy
Intercept Pharmaceuticals

Start price
Target price
Perf. (%)
€17.43
18.09.22
-
18.09.23
-17.30%
01.10.22

Risky Investment
daimler1 
18.09.22 50%
sell
Avenue Therapeutics Inc.

Start price
Target price
Perf. (%)
€8.29
27.09.22
-
27.09.23
26.64%
01.10.22

Risky Investment
daimler1 
27.09.22 50%
buy
Intercept Pharmaceuticals

Start price
Target price
Perf. (%)
€15.08
21.09.22
-
21.09.23
-4.44%
01.10.22

Risky Investment
Vassago1 
21.09.22 50%
sell
Prothena Corp. plc

Start price
Target price
Perf. (%)
€54.86
28.09.22
-
28.09.23
12.14%
01.10.22

Risky Investment
Vassago1 
28.09.22 50%
buy
Forte Biosciences Inc.

Start price
Target price
Perf. (%)
€1.21
19.09.22
-
19.09.23
-12.19%
01.10.22

Capable Management
Could be very worthwhile Investment >20% year
Few uniques
me8 
19.09.22 0%
buy
Intercept Pharmaceuticals

Start price
Target price
Perf. (%)
€16.65
20.09.22
€32.00
31.01.23
-17.72%
30.09.22

Could be very worthwhile Investment >20% year
BiotechBee 
20.09.22 40%
buy
Nicox S.A.

Start price
Target price
Perf. (%)
€3.19
29.09.21
€3.80
29.09.22
-46.37%
30.09.22

Could be worthwhile Investment >10% per year
melinda 
29.09.21 50%
sell
Apellis Pharmaceuticals

Start price
Target price
Perf. (%)
€64.19
07.09.22
€35.00
31.12.24
8.24%
29.09.22

Could be very worthwhile Investment >20% year
BiotechBee 
07.09.22 50%
buy
BeiGene Ltd ADR

Start price
Target price
Perf. (%)
€312.00
28.09.21
-
28.09.22
-54.17%
28.09.22

Saftman 
28.09.21 50%
buy
Genfit S.A.

Start price
Target price
Perf. (%)
€3.36
26.09.21
-
26.09.22
14.15%
27.09.22

Could be worthwhile Investment >10% per year
melinda 
26.09.21 40%
buy
Arbutus Biopharma Corp.

Start price
Target price
Perf. (%)
€2.39
03.08.22
€2.80
03.08.23
-14.19%
20.09.22

Differentiated customer and product portfolio
Lower EBIT Margin than peer group
High valuation
Very low/no dividend yield expected
geldnutzer 
03.08.22 50%
buy
Inovio Pharma

Start price
Target price
Perf. (%)
€2.12
03.08.22
€2.60
03.08.23
-11.19%
20.09.22

Very low/no dividend yield expected
Risky balance sheet
ROE lower than 10% per year
Increased challenges to pay loans and raise capital
geldnutzer 
03.08.22 50%
sell
MacroGenics Inc.

Start price
Target price
Perf. (%)
€16.79
19.09.21
-
19.09.22
-79.51%
20.09.22

Probably not worthwhile Investment
Lokrim 
19.09.21 20%
sell
Abeona Therapeutics Inc.

Start price
Target price
Perf. (%)
€25.05
19.09.21
-
19.09.22
-85.23%
20.09.22

Growths faster than the competition
Risky Investment
Lokrim 
19.09.21 10%